Marshwinds Advisory’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,225
Closed -$269K 137
2017
Q3
$269K Sell
9,225
-775
-8% -$22.9K 0.12% 114
2017
Q2
$322K Sell
10,000
-301
-3% -$9.88K 0.15% 112
2017
Q1
$356K Sell
10,301
-525
-5% -$18.7K 0.17% 105
2016
Q4
$382K Sell
10,826
-400
-4% -$13.5K 0.18% 106
2016
Q3
$390K Sell
11,226
-100
-0.9% -$3.5K 0.19% 105
2016
Q2
$423K Hold
11,326
0.21% 102
2016
Q1
$458K Sell
11,326
-724
-6% -$27K 0.24% 94
2015
Q4
$434K Sell
12,050
-100
-0.8% -$3.62K 0.23% 97
2015
Q3
$388K Sell
12,150
-1,100
-8% -$37.5K 0.21% 104
2015
Q2
$450K Sell
13,250
-150
-1% -$5.05K 0.23% 98
2015
Q1
$453K Buy
13,400
+350
+3% +$12.2K 0.21% 104
2014
Q4
$458K Buy
13,050
+140
+1% +$4.71K 0.22% 103
2014
Q3
$423K Buy
+12,910
New +$439K 0.21% 103

Other funds holding ACH

Marshwinds Advisory's ACH Position: Q4 2017 in Review

Marshwinds Advisory sold out of Accendra Health (ACH) in Q4 2017, closing a stake of 9,225 shares — an estimated $269K sold.

Marshwinds Advisory first reported a position in ACH in Q3 2014 and held it in 13 quarters. The position peaked at $458K in Q1 2016. 230 funds tracked by Wall St. Rank hold ACH as of Q4 2017.

  • Marshwinds Advisory reported no remaining Accendra Health position as of Q4 2017 after selling out during the quarter.
  • Marshwinds Advisory sold 9,225 Accendra Health shares in Q4 2017, an estimated $269K.
  • Marshwinds Advisory first reported a position in Accendra Health in Q3 2014 and held it in 13 quarters.
  • Marshwinds Advisory's Accendra Health position peaked at $458K in Q1 2016.
  • 230 funds tracked by Wall St. Rank held Accendra Health as of Q4 2017.

Based on Marshwinds Advisory's 13F filing for Q4 2017, filed 8 Jan 2018.